Zhang Guiying, Liu Ting, Chen Yong-Heng, Chen Yuxiang, Xu Meihua, Peng Jie, Yu Shuyi, Yuan Jianwei, Zhang Xiuwu
Department of Gastroenterology, Xiangya Hospital, Central South University, Hunan Province, P.R. China.
Clin Cancer Res. 2009 Jan 1;15(1):201-7. doi: 10.1158/1078-0432.CCR-08-1094.
This study aimed to develop an efficient and safe strategy to introduce suicide genes into colon cancer cells.
In this study, we fused an enhanced carcinoembryonic antigen promoter (CEA) to a suicide gene, cytosine deaminase (CD). This construct was delivered into colon cancer cells using calcium phosphate nanoparticles (CPNP). The cells were then treated with the prodrug 5-FC. The therapeutic effect was evaluated in vitro and in vivo.
Our study showed that the CEA promoter-driven, CPNP-delivered suicide gene was only expressed in CEA-positive colon cancer cells, and resulted in significant cytotoxicity after administration of the prodrug 5-FC in vitro. Moreover, our in vivo study showed that CPNP-mediated CEA-CD delivery, together with 5-FC treatment, resulted in significant tumor growth delay in xenograft human colon carcinoma.
Our study indicates that the combination of CPNP and CEA-CD gene expression represents a novel approach for CEA-positive tumor gene therapy.
本研究旨在开发一种高效且安全的策略,将自杀基因导入结肠癌细胞。
在本研究中,我们将增强型癌胚抗原启动子(CEA)与自杀基因胞嘧啶脱氨酶(CD)融合。使用磷酸钙纳米颗粒(CPNP)将该构建体导入结肠癌细胞。然后用前药5-FC处理细胞。在体外和体内评估治疗效果。
我们的研究表明,CEA启动子驱动、CPNP递送的自杀基因仅在CEA阳性结肠癌细胞中表达,并在体外给予前药5-FC后产生显著的细胞毒性。此外,我们的体内研究表明,CPNP介导的CEA-CD递送与5-FC治疗相结合,导致异种移植人结肠癌的肿瘤生长显著延迟。
我们的研究表明,CPNP与CEA-CD基因表达的组合代表了一种针对CEA阳性肿瘤基因治疗的新方法。